AnaSpec has introduced its newest antibody solutions – anti-MMP-1 (Hinge) and anti-MMP-13 (Hinge) antibodies. Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in experiments. In response to customers’ suggestions, AnaSpec’s anti-MMP antibodies are packaged in efficient 50 ul sizes.
Matrix metalloproteinases (MMPs) are a family of highly homologous protein-degrading zinc dependent enzymes endopeptidases. These enzymes are responsible for the breakdown of connective tissues and are important in many normal biological processes including embryonic development, angiogenesis, bone remodeling, menstrual cycle, and wound healing. They are also involved in pathological processes such as inflammation, cancer, multiple sclerosis, Alzheimer’s, malignant gliomas, lupus, arthritis, periodontis, emphysema, glomerulonephritis, atherosclerosis, tissue ulceration, and tissue destruction. Imbalanced secretion of certain MMPs or disturbances in the differential control of MMP by tissue inhibitor of MMPs (TIMPs) is implicated in the invasive potential of malignant tumors.
This family currently includes more than 25 members that can be divided into collagenases (MMP-1, -8, -13 and -18), gelatinases (MMP-2 and -9), stromelysins (MMP-3 –7, -10, -11and -13), matrilysins (MMP-7 and -26), elastins (MMP-12), and the membrane-type MMPs (MMP-14 to –17, -20, and -21), according to their structure and substrate specificity.
Anti-MMP-1 (Hinge), Collagenase-
Rabbit polyclonal anti-MMP-1 (Hinge) antibody was raised against a synthetic collagenase-
Anti-MMP-13 (Hinge), Collagenase-
Rabbit anti-MMP-13 (Hinge) polyclonal antibody was raised against a synthetic collagenase-
For more information, visit http://www.anaspec.com/
Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies:
For more information, visit www.anaspec.com
References:
1. Woessner, JF. Jr. and CJ. Taplin, J. Biol. Chem. 263, 16918 (1988).
2. Woessner, JF..Jr. FASEB J. 5, 2145 (1991).
3. Goldberg, GI. et al. Ann. NY. Acad. Sci. 580, 375 (1990).
4. Stetler-
5. Gravallese, EM. et al. Arthritis Rheum. 34, 1076 (1991).
6. Gabison, e. et al. Am. J. Pathology 166, 209 (2005).
7. Freije, JM. et al. J. Biol. Chem. 269, 16766 (1994)